Non-small-cell lung cancer (NSCLC) is one of the most frequent cancer types and is
responsible for the majority of cancer-related deaths worldwide. The management of …

Lung cancer is associated with a heavy cancer-related burden in terms of patients' physical
and mental health worldwide. Two randomized controlled trials, the US-National Lung …

Background Individual plasma proteins have been identified as minimally invasive
biomarkers for lung cancer diagnosis with potential utility in early detection. Plasma …

Cancer is one of the leading causes of death worldwide. Early cancer detection is critical
because it can significantly improve treatment outcomes, thus saving lives, reducing …

Lung cancer (LC) causes few symptoms in the earliest stages, leading to one of the highest
mortality rates among cancers. Low-dose computerised tomography (LDCT) is used to …

Background Lung cancer is associated with the greatest cancer mortality as it typically
presents with incurable distributed disease. Biomarkers relevant to risk assessment for the …

Early-stage screening of cancer is critical in preventing its development and therefore can
improve the prognosis of the disease. One accurate and effective method of cancer …

Identification of risk biomarkers may enhance early detection of smoking-related lung
cancer. We measured between 392 and 1,162 proteins in blood samples drawn at most …

PURPOSE To investigate the utility of integrating a panel of circulating protein biomarkers in
combination with a risk model on the basis of subject characteristics to identify individuals at …

The Oncology Grand Rounds series is designed to place original reports published in the
Journal into clinical context. A case presentation is followed by a description of diagnostic …